Gut microbiota: a potential key player in boosting immune reconstitution of immunological nonresponders

References

• 1. Kelley CF, Kitchen CM, Hunt PW et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin. Infect. Dis. 48(6), 787–794 (2009).
  MedlineGoogle Scholar
• 2. Pickard JM, Zeng MY, Caruso R, Núñez G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 279(1), 70–89 (2017).
  Medline CASGoogle Scholar
• 3. Vujkovic-Cvijin I, Somsouk M. HIV and the gut microbiota: composition, consequences, and avenues for amelioration. Curr. HIV/AIDS Rep. 16(3), 204–213 (2019).
  MedlineGoogle Scholar
• 4. Ouyang J, Lin J, Isnard S et al. The bacterium Akkermansia muciniphila: a sentinel for gut permeability and its relevance to HIV-related inflammation. Front. Immunol. 11, 645 (2020).
  Medline CASGoogle Scholar
• 5. Rocafort M, Noguera-Julian M, Rivera J et al. Evolution of the gut microbiome following acute HIV-1 infection. Microbiome 7(1), 73 (2019).
  MedlineGoogle Scholar
• 6. Cohen MS, Chen YQ, Mccauley M et al. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365(6), 493–505 (2011).
  Medline CASGoogle Scholar
• 7. Serrano-Villar S, Rojo D, Martínez-Martínez M et al. Gut bacteria metabolism impacts immune recovery in HIV-infected individuals. EBioMedicine 8, 203–216 (2016).
  MedlineGoogle Scholar
• 8. Lu W, Feng Y, Jing F et al. Association between gut microbiota and CD4 recovery in HIV-1 infected patients. Front. Microbiol. 9, 1451 (2018).
  MedlineGoogle Scholar
• 9. Xie Y, Sun J, Wei L et al. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals. BMC Microbiol. 21(1), 11 (2021).
  Medline CASGoogle Scholar
• 10. Nganou-Makamdop K, Talla A, Sharma AA et al. Translocated microbiome composition determines immunological outcome in treated HIV infection. Cell 184(15), 3899–3914.e3816 (2021).
  Medline CASGoogle Scholar
• 11. Heung LJ, Luberto C, Del Poeta M. Role of sphingolipids in microbial pathogenesis. Infect. Immun. 74(1), 28–39 (2006).
  Medline CASGoogle Scholar
• 12. Schenk B, Fernandez F, Waechter CJ. The ins(ide) and out(side) of dolichyl phosphate biosynthesis and recycling in the endoplasmic reticulum. Glycobiology 11(5), 61r–70r (2001).
  Medline CASGoogle Scholar
• 13. Archin NM, Margolis DM. Emerging strategies to deplete the HIV reservoir. Curr. Opin. Infect. Dis. 27(1), 29–35 (2014).
  Medline CASGoogle Scholar
• 14. Wegiel B, Otterbein LE. Go green: the anti-inflammatory effects of biliverdin reductase. Front. Pharmacol. 3, 47 (2012).
  MedlineGoogle Scholar
• 15. Davar D, Dzutsev AK, Mcculloch JA et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science 371(6529), 595–602 (2021).
  Medline CASGoogle Scholar
• 16. Geng ST, Zhang JB, Wang YX et al. Pre-digested protein enteral nutritional supplementation enhances recovery of CD4(+) T cells and repair of intestinal barrier in HIV-infected immunological non-responders. Front. Immunol. 12, 757935 (2021).
  Medline CASGoogle Scholar
• 17. Olivas-Martínez I, Rosado-Sánchez I, Cordero-Varela JA et al. Partial restoration of gut-mucosal dysbiosis in late-treated HIV-infected subjects with CD4 T-cell recovery. Clin. Transl. Med. 12(4), e788 (2022).
  Medline CASGoogle Scholar